Oncolys shares still ahead after $46m IPO
This article was originally published in Scrip
Executive Summary
The Japanese venture Oncolys BioPharma has floated on the Mothers high-tech market of the Tokyo Stock Exchange, raising around JPY4.7bn ($46m) to develop its pipeline of drugs and diagnostics for cancer and serious infections.